Jiangsu Changyou Environmental Protection Technology
301557
Hefei conver Holding
603409
LIERDA
832149
4
SHENGNAN TECHNOLOGY
837006
5
CHK
831167
CN Stock MarketDetailed Quotes
000952 Hubei Guangji Pharmaceutical
- 5.67
- +0.01+0.18%
Not Open Mar 4 15:00 CST
1.98BMarket Cap-8.55P/E (TTM)
5.69High5.60Low44.33KlotVolume5.69Open5.66Pre Close25.01MTurnover1.29%Turnover RatioLossP/E (Static)349.86MShares7.8552wk High1.65P/B1.95BFloat Cap4.6952wk Low6.23Limit Up343.99MShs Float42.70Historical High5.09Limit Down1.59%Amplitude0.72Historical Low--Dividend TTM5.64Avg Price24.06KlotAsk--Div YieldTTM100Lot Size18.87KlotBid
Hubei Guangji Pharmaceutical News
Guangji Pharmaceutical: Announcement on changing the registered capital and amending some provisions of the “Articles of Association”
Guangji Pharmaceutical: Announcement on Obtaining a Drug Registration Certificate for Fibustel Tablets
Guangji Pharmaceutical: Announcement on the public listing of the wholly-owned subsidiary Hubei Guanghua Pharmaceutical Co., Ltd. to increase capital and expand shares
Guangji Pharmaceutical: Progress Notice on Participation in Bankruptcy and Reorganization Investments
Guangji Pharmaceutical: Notice on Obtaining a Notice of Approval for Supplementary Applications for Valaciclovir Hydrochloride Tablets
Guangji Pharmaceutical: Announcement on signing a strategic cooperation agreement with Qingdao Guoxin Pharmaceutical Co., Ltd.
Guangji Pharmaceutical: Announcement on signing a strategic cooperation agreement with Pingguang Pharmaceutical Co., Ltd.
Guangji Pharmaceutical: Prompt Announcement on Pre-listing of Wholly-owned Subsidiaries on Capital Increase and Stock Expansion
Guangji Pharmaceutical: Announcement on the Appointment of Senior Executives and Securities Affairs Representatives
Guangji Pharmaceutical: Announcement on asset impairment preparations for the first three quarters of 2024
Guangji Pharmaceutical: Notice on receiving the “Notice of Case Filing” from the China Securities Regulatory Commission
Guangji Pharmaceutical: Legal Opinion Witnessing the 2024 Third Extraordinary General Meeting of Shareholders of Hubei Guangji Pharmaceutical Co., Ltd.
Guangji Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Guangji Pharmaceutical: Announcement on the completion of the general election of the Board of Directors and the Board of Supervisors
Guangji Pharmaceutical: Announcement on the election of the board of directors for a new term
Guangji Pharmaceutical: Announcement on the election of the Supervisory Board for a new term
Guangji Pharmaceutical: Announcement on Election of Staff Representative Supervisors for the 11th Board of Supervisors
Guangji Pharmaceutical: Opinions of the 10th Board of Directors Nomination Committee on the Eligibility of Candidates for the 11th Board of Directors
Guangji Pharmaceutical: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Guangji Pharmaceutical: Legal Opinion Witnessing the 2024 Second Extraordinary General Meeting of Shareholders of Hubei Guangji Pharmaceutical Co., Ltd.